Molecules/ETIGILIMAB

ETIGILIMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: T-cell immunoreceptor with Ig and ITIM domains inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ETIGILIMABOMP-313M32

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ETIGILIMAB

Loading drug network...